Status:
UNKNOWN
Acute Kidney Injury Among Pediatric Cancer Patients At South Egypt Cancer Institute
Lead Sponsor:
Assiut University
Conditions:
To Determine the Cumulative Incidence of AKI Using KDIGO Criteria in Pediatric Patients With Malignancy in South Egypt Cancer Institute (SECI)
Eligibility:
All Genders
30-18 years
Brief Summary
Cancer is the second most frequent cause of premature death in children. The incidence of pediatric cancer varies by region and country, but it is generally considered rare with an estimated 300,000 n...
Detailed Description
* Primary: To determine the cumulative incidence of AKI using KDIGO criteria in pediatric patients with malignancy in South Egypt Cancer Institute (SECI) * Secondary: 1. Incidence of Hospital-acqui...
Eligibility Criteria
Inclusion
- • Children of both sexes (aged from 1 month to 18 years at diagnosis)
- Patients with either hematological malignancies or solid tumors admitted to the Paediatric Oncology and Haematological Malignancies Department
Exclusion
- Children who had an unconfirmed cancer diagnosis.
- Children more than 18 years at diagnosis.
- Children with preexisting chronic kidney disease (CKD) that defined as the presence of structural or functional kidney damage that persist over minimum of three month
- The patient underwent hematopoietic stem cell transplantation. Patients with 1 s.Cr level.
- Patient underwent renal transplant.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT06081608
Start Date
November 1 2023
End Date
September 1 2024
Last Update
October 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.